Next Article in Journal
Sensitive Detection of KRAS Mutations by Clustered Regularly Interspaced Short Palindromic Repeats
Next Article in Special Issue
Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBDN318-V510) Expressed in Escherichia coli
Previous Article in Journal
Animal Models of Depression: What Can They Teach Us about the Human Disease?
Previous Article in Special Issue
COVID-19 Point-of-Care Diagnostics That Satisfy Global Target Product Profiles
Review

SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations

1
Department of Biochemistry and Molecular Medicine and Hospital Universitario “Dr. Jose E. Gonzalez”, Universidad Autonoma de Nuevo León, Monterrey 64460, Mexico
2
Instituto Tecnologico de Tlahuac II, Tecnologico de Mexico, Mexico City 13550, Mexico
*
Author to whom correspondence should be addressed.
Diagnostics 2021, 11(1), 124; https://doi.org/10.3390/diagnostics11010124
Received: 17 November 2020 / Revised: 9 December 2020 / Accepted: 19 December 2020 / Published: 14 January 2021
The new coronavirus that was first identified in December 2019 in Wuhan China, now called SARS-CoV-2, which causes the disease called COVID-19, has spread from China to the entire world in a few months. Due to its contagious potential (R0: 5.7) and because there is still no effective treatment to stop the infection, and a vaccine for prevention it is not yet available to the general population, COVID-19 is currently considered a global health problem. The need to implement sensitive methods for the identification of individuals with COVID-19 has led to the development of different molecular and immunological tests. The importance of a timely and accurate diagnosis is essential to determine the course of the pandemic. The interpretation of the results obtained by each test as well as the factors that affect these results have not been fully described. In this review, we describe and analyze the different SARS-CoV-2 detection methods that have been performed in Mexico and are available worldwide, outlining their strengths and weaknesses. Further, a broader perspective of the correct use and interpretation of the results obtained with these diagnostic tools is proposed to improve the containment strategy and identify the true impact of the pandemic. View Full-Text
Keywords: SARS-CoV-2; IgG; antibodies; IgM; COVID-19; diagnostic test; immunoassay; ELISA; CLIA; rapid test; lateral flow assay; viral detection; immune host response SARS-CoV-2; IgG; antibodies; IgM; COVID-19; diagnostic test; immunoassay; ELISA; CLIA; rapid test; lateral flow assay; viral detection; immune host response
Show Figures

Figure 1

MDPI and ACS Style

Martinez-Liu, C.; Martínez-Acuña, N.; Arellanos-Soto, D.; Galan-Huerta, K.; Lozano-Sepulveda, S.; Martínez-Guzmán, M.d.C.; Rivas-Estilla, A.M. SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations. Diagnostics 2021, 11, 124. https://doi.org/10.3390/diagnostics11010124

AMA Style

Martinez-Liu C, Martínez-Acuña N, Arellanos-Soto D, Galan-Huerta K, Lozano-Sepulveda S, Martínez-Guzmán MdC, Rivas-Estilla AM. SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations. Diagnostics. 2021; 11(1):124. https://doi.org/10.3390/diagnostics11010124

Chicago/Turabian Style

Martinez-Liu, Cynthia, Natalia Martínez-Acuña, Daniel Arellanos-Soto, Kame Galan-Huerta, Sonia Lozano-Sepulveda, María d.C. Martínez-Guzmán, and Ana M. Rivas-Estilla. 2021. "SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations" Diagnostics 11, no. 1: 124. https://doi.org/10.3390/diagnostics11010124

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop